RXRX vs VTI
Recursion Pharmaceuticals Inc (RXRX) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
VTI does not have a complete income-statement cache yet.
RXRX currently screens at market cap $1.75B. VTI currently screens at market cap $0.
Not investment advice. Open the RXRX and VTI stock pages for the full models.
Not investment advice.